default author photo

Ying Fan

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC)

SCHOLARLY PAPERS

2

DOWNLOADS

53

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

The Different Sequences of Cdk4/6 Inhibitor and Mtor Inhibitor in Hr+/Her2- Advanced Breast Cancer: A Multicenter Real-World Study

Number of pages: 19 Posted: 22 Jul 2024
Yuqian Liao, Yujing Tan, Yipeng Li, Fei Ma, Jiayu Wang, Pin Zhang, Qing Li, Qiao Li, Yang Luo, Bo Lan, Shanshan chen, Binghe Xu, Hanfang Jiang, Weihong Zhao and Ying Fan
Jiangxi Medical College, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), affiliation not provided to SSRN, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences - Department of Medical Oncology, Beijing University, Government of the People's Republic of China - Chinese PLA General Hospital and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC)
Downloads 30 (1,318,317)

Abstract:

Loading...

therapeutic sequence, CDK4/6 inhibitor, everolimus, survival outcome

2.

Dynamic Hematological Indicators Predict the Efficacy of Cdk4/6 Inhibitors in Hr-Positive, Her2-Negative Metastatic Breast Cancer: An Exploratory Analysis of the Bright-2 Trial

Number of pages: 21 Posted: 06 Aug 2025
Hangcheng Xu, Yan Wang, Qiang Sa, Yiran Zhou, Fei Ma, Pin Zhang, Ying Fan, Ruigang Cai, Qiao Li, Bo Lan, Jiani Wang, Liang Cui, Xinxin Tan, Jing Bai, Yan Hu, Xianghui Duan, Fan Yang, Jiayu Wang and Binghe Xu
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Chinese Academy of Medical Sciences - Department of Medical Oncology, Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), affiliation not provided to SSRN, Tianjin Medical University - National Clinical Research Center for Cancer, Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Geneplus Beijing Institute, Geneplus Beijing Institute, Geneplus-Beijing Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 23 (1,411,822)

Abstract:

Loading...

Metastatic Breast Cancer, HR-positive, CDK4/6 inhibitor, prognostic factor, hematological indicator